Saba Capital Management, L.P. sold HQL

September 16, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 2,026 shares of Abrdn Life Sciences Investors at $13.99 per share, a transaction worth $28.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.